RECRUITINGOBSERVATIONAL
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations (GeM-PEx)
About This Trial
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
Who May Be Eligible (Plain English)
Who May Qualify:
- 6- 25 years old
- Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
- access to a smart phone and/or internet connection and the ability to complete remote telehealth visits
Who Should NOT Join This Trial:
- known type 1 or type 2 diabetes, monogenic diabetes
- critical illness requiring admission to the ICU
- pregnancy
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* 6- 25 years old
* Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
* access to a smart phone and/or internet connection and the ability to complete remote telehealth visits
Exclusion Criteria:
* known type 1 or type 2 diabetes, monogenic diabetes
* critical illness requiring admission to the ICU
* pregnancy
Locations (1)
Children's Hospital Colorado, University of Colorado Denver
Aurora, Colorado, United States